Kinetics of neutralizing antibodies in patients naturally infected by H5N1 virus. 2010

Philippe Buchy, and Sirenda Vong, and Simon Chu, and Jean-Michel Garcia, and Tran Tinh Hien, and Vo Minh Hien, and Mey Channa, and Do Quang Ha, and Nguyen Van Vinh Chau, and Cameron Simmons, and Jeremy J Farrar, and Malik Peiris, and Menno D de Jong
Institut Pasteur in Cambodia, Phnom Penh, Cambodia. pbuchy@pasteur-kh.org

BACKGROUND Little is known about the kinetics of anti-H5 neutralizing antibodies in naturally H5N1-infected patients with severe clinical illness or asymptomatic infection. METHODS Using H5N1 microneutralisation (MN) and H5-pseudotype particle-based microneutralisation assays (H5pp) we analyzed sera sequentially obtained from 11 severely ill patients diagnosed by RT-PCR (follow-up range 1-139 weeks of disease onset) and 31 asymptomatically infected individuals detected in a sero-epidemiological study after exposure to H5N1 virus (follow-up range: 1-2 month-11 months after exposure). RESULTS Of 44 sera from 11 patients with H5N1 disease, 70% tested positive by MN (antibody titre > or = 80) after 2 weeks and 100% were positive by 3 weeks after disease onset. The geometric mean MN titers in severely ill patients were 540 at 1-2 months and 173 at 10-12 months and thus were higher than the titers from asymptomatic individuals (149 at 1-2 months, 62.2 at 10-12 months). Fractional polynomial regression analysis demonstrated that in all severely ill patients, positive titers persisted beyond 2 years of disease onset, while 10 of 23 sera collected 10-11 months after exposure in asymptomatically infected individuals tested negative. CONCLUSIONS Our results indicate that people with asymptomatic H5N1 infection have lower H5N1 antibody titres compared to those with severe illness and that in many asymptomatically infected patients the antibody titer decreased to levels below the threshold of positivity within one year. These data are essential for the design and interpretation of sero-epidemiological studies.

UI MeSH Term Description Entries
D007251 Influenza, Human An acute viral infection in humans involving the respiratory tract. It is marked by inflammation of the NASAL MUCOSA; the PHARYNX; and conjunctiva, and by headache and severe, often generalized, myalgia. Grippe,Human Flu,Human Influenza,Influenza in Humans,Influenza,Flu, Human,Human Influenzas,Influenza in Human,Influenzas,Influenzas, Human
D007700 Kinetics The rate dynamics in chemical or physical systems.
D009500 Neutralization Tests The measurement of infection-blocking titer of ANTISERA by testing a series of dilutions for a given virus-antiserum interaction end-point, which is generally the dilution at which tissue cultures inoculated with the serum-virus mixtures demonstrate cytopathology (CPE) or the dilution at which 50% of test animals injected with serum-virus mixtures show infectivity (ID50) or die (LD50). Neutralization Test,Test, Neutralization,Tests, Neutralization
D012044 Regression Analysis Procedures for finding the mathematical function which best describes the relationship between a dependent variable and one or more independent variables. In linear regression (see LINEAR MODELS) the relationship is constrained to be a straight line and LEAST-SQUARES ANALYSIS is used to determine the best fit. In logistic regression (see LOGISTIC MODELS) the dependent variable is qualitative rather than continuously variable and LIKELIHOOD FUNCTIONS are used to find the best relationship. In multiple regression, the dependent variable is considered to depend on more than a single independent variable. Regression Diagnostics,Statistical Regression,Analysis, Regression,Analyses, Regression,Diagnostics, Regression,Regression Analyses,Regression, Statistical,Regressions, Statistical,Statistical Regressions
D002160 Cambodia A country located in Southeastern Asia, bordering the Gulf of Thailand, between Thailand, Vietnam, and Laos. The capital is Phnom Penh. Kampuchea,Khmer Republic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D014744 Vietnam A country in southeastern Asia, bordering the Gulf of Thailand, Gulf of Tonkin, and South China Sea, as well as China, Laos, and Cambodia. The capital is Hanoi. North Vietnam,Viet Nam,Vietnam, Republic of
D053124 Influenza A Virus, H5N1 Subtype A subtype of INFLUENZA A VIRUS comprised of the surface proteins hemagglutinin 5 and neuraminidase 1. The H5N1 subtype, frequently referred to as the bird flu virus, is endemic in wild birds and very contagious among both domestic (POULTRY) and wild birds. It does not usually infect humans, but some cases have been reported. H5N1 Avian Influenza Virus,H5N1 Bird Flu Virus,H5N1 Virus,H5N1 subtype,H5N1 Viruses,H5N1 subtypes,Virus, H5N1

Related Publications

Philippe Buchy, and Sirenda Vong, and Simon Chu, and Jean-Michel Garcia, and Tran Tinh Hien, and Vo Minh Hien, and Mey Channa, and Do Quang Ha, and Nguyen Van Vinh Chau, and Cameron Simmons, and Jeremy J Farrar, and Malik Peiris, and Menno D de Jong
February 2020, Biomedical and environmental sciences : BES,
Philippe Buchy, and Sirenda Vong, and Simon Chu, and Jean-Michel Garcia, and Tran Tinh Hien, and Vo Minh Hien, and Mey Channa, and Do Quang Ha, and Nguyen Van Vinh Chau, and Cameron Simmons, and Jeremy J Farrar, and Malik Peiris, and Menno D de Jong
September 1966, Ceskoslovenska epidemiologie, mikrobiologie, imunologie,
Philippe Buchy, and Sirenda Vong, and Simon Chu, and Jean-Michel Garcia, and Tran Tinh Hien, and Vo Minh Hien, and Mey Channa, and Do Quang Ha, and Nguyen Van Vinh Chau, and Cameron Simmons, and Jeremy J Farrar, and Malik Peiris, and Menno D de Jong
February 2010, Virology journal,
Philippe Buchy, and Sirenda Vong, and Simon Chu, and Jean-Michel Garcia, and Tran Tinh Hien, and Vo Minh Hien, and Mey Channa, and Do Quang Ha, and Nguyen Van Vinh Chau, and Cameron Simmons, and Jeremy J Farrar, and Malik Peiris, and Menno D de Jong
February 1995, Journal of virology,
Philippe Buchy, and Sirenda Vong, and Simon Chu, and Jean-Michel Garcia, and Tran Tinh Hien, and Vo Minh Hien, and Mey Channa, and Do Quang Ha, and Nguyen Van Vinh Chau, and Cameron Simmons, and Jeremy J Farrar, and Malik Peiris, and Menno D de Jong
July 2008, Journal of virology,
Philippe Buchy, and Sirenda Vong, and Simon Chu, and Jean-Michel Garcia, and Tran Tinh Hien, and Vo Minh Hien, and Mey Channa, and Do Quang Ha, and Nguyen Van Vinh Chau, and Cameron Simmons, and Jeremy J Farrar, and Malik Peiris, and Menno D de Jong
June 1993, Journal of clinical microbiology,
Philippe Buchy, and Sirenda Vong, and Simon Chu, and Jean-Michel Garcia, and Tran Tinh Hien, and Vo Minh Hien, and Mey Channa, and Do Quang Ha, and Nguyen Van Vinh Chau, and Cameron Simmons, and Jeremy J Farrar, and Malik Peiris, and Menno D de Jong
November 2009, PloS one,
Philippe Buchy, and Sirenda Vong, and Simon Chu, and Jean-Michel Garcia, and Tran Tinh Hien, and Vo Minh Hien, and Mey Channa, and Do Quang Ha, and Nguyen Van Vinh Chau, and Cameron Simmons, and Jeremy J Farrar, and Malik Peiris, and Menno D de Jong
January 2015, PloS one,
Philippe Buchy, and Sirenda Vong, and Simon Chu, and Jean-Michel Garcia, and Tran Tinh Hien, and Vo Minh Hien, and Mey Channa, and Do Quang Ha, and Nguyen Van Vinh Chau, and Cameron Simmons, and Jeremy J Farrar, and Malik Peiris, and Menno D de Jong
April 2006, Emerging infectious diseases,
Philippe Buchy, and Sirenda Vong, and Simon Chu, and Jean-Michel Garcia, and Tran Tinh Hien, and Vo Minh Hien, and Mey Channa, and Do Quang Ha, and Nguyen Van Vinh Chau, and Cameron Simmons, and Jeremy J Farrar, and Malik Peiris, and Menno D de Jong
March 2007, Virology,
Copied contents to your clipboard!